Long-term treatment costs and cost-effectiveness of restoration repair versus replacement

被引:7
|
作者
Kanzow, Philipp [1 ]
Krois, Joachim [2 ]
Wiegand, Annette [1 ]
Schwendicke, Falk [2 ]
机构
[1] Univ Med Ctr Gottingen, Dept Prevent Dent Periodontol & Cariol, Robert Koch Str 40, D-37075 Gottingen, Germany
[2] Charite Univ Med Berlin, Dept Oral Diagnost Digital Hlth & Hlth Serv Res, Berlin, Germany
关键词
Composite materials; Cost-effectiveness; Minimally invasive dentistry; Restoration repair; Restorative dentistry; Treatment costs; POSTERIOR COMPOSITE RESTORATIONS; LONGEVITY; MOLARS; CARE;
D O I
10.1016/j.dental.2021.02.008
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Objectives. When managing partially defective restorations, dentists can choose between repair and replacement. We aimed to assess the long-term treatment costs of repairs and replacements. Methods. Partially defective anterior and posterior composite restorations in permanent teeth had been repaired or replaced in a German university hospital and were retrospectively followed until censoring or one of the following events: (1) Extraction, (2) Major complications including placement of indirect restorations, endodontic treatments and extractions, or (3) Any complications including major complications and further direct restorations. Costs were estimated from a German mixed public-private-payer perspective. Cost-effectiveness differences were described using median-based incremental-cost-effectiveness ratios (ICERMEDIAN). Statistical analysis was performed using generalized linear mixed modeling (GLM), Chi(2)-test, and Wilcoxon rank-sum test (p < 0.05). Results. A total of 616 repairs in 468 patients (follow-up: 4.9 +/- 4.1 years) and 264 replacements in 218 patients (follow-up: 4.8 +/- 4.3) were included. While replacements were associated with higher initial treatment costs, median annualized treatment costs did not significantly differ between repair (47.58 Euro [IQR: 24.41-107.04]) and replacement (50.64 Euro [IQR: 26.30-118.78]; p > 0.05), but were higher for molars (75.53 Euro [IQR: 24.41-92.18]) than incisors (45.03 Euro [IQR: 28.19-168.50]; p = 0.011). The difference in the % of extractions, major and any complications were minimal between both groups. The mean ICERMEDIAN of replacement vs. repair was -146.8 Euro/% when extractions were considered as outcomes. Regarding major and any complications, mean ICERMEDIAN amounted to 67.6 Euro/% and 23.9Euro/%, respectively. Significance. Repairs and replacements of partially defective restorations showed similar long-term costs and cost-effectiveness. (C) 2021 The Academy of Dental Materials. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:E375 / E381
页数:7
相关论文
共 50 条
  • [1] Long-term effectiveness and cost-effectiveness of antiviral treatment in hepatitis C
    Sroczynski, G.
    Esteban, E.
    Conrads-Frank, A.
    Schwarzer, R.
    Muehlberger, N.
    Wright, D.
    Zeuzem, S.
    Siebert, U.
    JOURNAL OF VIRAL HEPATITIS, 2010, 17 (01) : 34 - 50
  • [2] Long-term cost-effectiveness of donepezil for the treatment of Alzheimer's disease
    Teipel, Stefan J.
    Ewers, Michael
    Reisig, Veronika
    Schweikert, Bernd
    Hampel, Harald
    Happich, Michael
    EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 2007, 257 (06) : 330 - 336
  • [3] Long-term cost-effectiveness of donepezil for the treatment of Alzheimer’s disease
    Stefan J. Teipel
    Michael Ewers
    Veronika Reisig
    Bernd Schweikert
    Harald Hampel
    Michael Happich
    European Archives of Psychiatry and Clinical Neuroscience, 2007, 257 : 330 - 336
  • [4] The long-term cost-effectiveness of oral semaglutide versus empagliflozin and dulaglutide in Portugal
    Samuel J. P. Malkin
    Davide Carvalho
    Catarina Costa
    Vasco Conde
    Barnaby Hunt
    Diabetology & Metabolic Syndrome, 14
  • [5] The long-term cost-effectiveness of oral semaglutide versus empagliflozin and dulaglutide in Portugal
    Malkin, Samuel J. P.
    Carvalho, Davide
    Costa, Catarina
    Conde, Vasco
    Hunt, Barnaby
    DIABETOLOGY & METABOLIC SYNDROME, 2022, 14 (01)
  • [6] The Long-Term Cost-Effectiveness of Oral Semaglutide Versus Lower-Cost Liraglutide in the UK
    Elnaggar, Mohamed
    Mansinho, Joana Nunes
    Malkin, Samuel J. P.
    Whitaker, Joseph
    Hunt, Barnaby
    Glah, Divina
    Maclellan, Martina
    Ali, Samina
    DIABETES THERAPY, 2025, : 613 - 628
  • [7] Long-Term Cost-Effectiveness of Disease Management in Systolic Heart Failure
    Miller, George
    Randolph, Stephen
    Forkner, Emma
    Smith, Brad
    Galbreath, Autumn Dawn
    MEDICAL DECISION MAKING, 2009, 29 (03) : 325 - 333
  • [8] A Systematic Review of the Cost-Effectiveness of Long-Term Mechanical Circulatory Support
    Nunes, Abraham J.
    MacArthur, Roderick G. G.
    Kim, Daniel
    Singh, Gurmeet
    Buchholz, Holger
    Chatterley, Patricia
    Klarenbach, Scott W.
    VALUE IN HEALTH, 2016, 19 (04) : 494 - 504
  • [9] Long-term cost-effectiveness of clopidogrel in STEMI patients
    Zhang, Zefeng
    Kolm, Paul
    Mosse, Frederique
    Jackson, Joseph
    Zhao, Liping
    Weintraub, William S.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2009, 135 (03) : 353 - 360
  • [10] The long-term effects and cost-effectiveness of success for all
    Borman, GD
    Hewes, GM
    EDUCATIONAL EVALUATION AND POLICY ANALYSIS, 2002, 24 (04) : 243 - 266